Page 1

www.medistim.com INTERIM REPORT MED STIM Q3 2021 Sales revenues for the quarter ended at MNOK 102.1 ( MNOK 83.4 ) , an increase of 22.5 % . Sales as of September ended at MNOK 309.2 ( MNOK 268.9 ) a 15.0 % increase . Sales in the USA increased by 11.9 % in NOK . Currency neutral growth was 24.9 % . Currency neutral sales of own products increased by 33 % for the quarter . Total revenues YTD September include the Paycheck Protection Program income and reach MNOK 314.5 . Operating result ( EBIT ) for the quarter ended at MNOK 25.1 ( MNOK 20.8 ) a 20.3 % increase . EBIT year to date September ended at MNOK 96.8 ( MNOK 73.3 ) , a 32.0 % increase . This is the best operating result YTD September ever . Cash flow from operations YTD was a solid MNOK 81.2 . Cash by the end of the quarter was MNOK 89.7 .